Atanas G. Atanasov

Atanas G. Atanasov is Principle Investigator of Ludwig Boltzmann Institute for Digital Health and Patient Safety (LBIDHPS) at Medical University of Vienna (Austria), Adjunct Professor at IGAB PAS (Poland), Guest-Professor at Bulgarian Academy of Sciences (Bulgaria), Guest-Lecturer at the University of Vienna (Austria), and Editor-in-Chief of Current Research in Biotechnology (CRBIOTECH, Elsevier).

Dr Atanasov holds MSc degree in Biotechnology, PhD degree in Biochemistry, and Habilitation (Privatdozent (PD) degree) in Pharmaceutical Biology (from the University of Vienna, Austria). He has published >200 papers in the areas of Molecular Medicine, Biotechnology, and Science Communication.  Moreover, Dr Atanas G. Atanasov is a distinguished promoter of digital science communication (e.g., using a >100 000-followers Twitter channel) and open innovation (e.g., through the executive administration of open innovation platforms focused on Digital Health and Patient Safety and on Molecular Pharmacology of Nature-derived Drugs).